BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 7728352)

  • 1. Processing of bacterial antigens for presentation to class I and II MHC-restricted T lymphocytes.
    Harding CV; Song R; Griffin J; France J; Wick MJ; Pfeifer JD; Geuze HJ
    Infect Agents Dis; 1995 Mar; 4(1):1-12. PubMed ID: 7728352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular basis for detection of infectious agents].
    Siegrist CA
    Schweiz Med Wochenschr; 1996 Feb; 126(7):246-54. PubMed ID: 8720322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.
    Pfeifer JD; Wick MJ; Roberts RL; Findlay K; Normark SJ; Harding CV
    Nature; 1993 Jan; 361(6410):359-62. PubMed ID: 7678924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules.
    Harding CV; Song R
    J Immunol; 1994 Dec; 153(11):4925-33. PubMed ID: 7963555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of subcellular organelles involved in major histocompatibility complex (MHC) class II-restricted antigen presentation by electrophoresis.
    Engering A; Lefkovits I; Pieters J
    Electrophoresis; 1997 Dec; 18(14):2523-30. PubMed ID: 9527480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic peptides bind to class II MHC molecules in an early lysosomal compartment.
    Harding CV; Geuze HJ
    J Immunol; 1993 Oct; 151(8):3988-98. PubMed ID: 8409381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-presentation in viral immunity and self-tolerance.
    Heath WR; Carbone FR
    Nat Rev Immunol; 2001 Nov; 1(2):126-34. PubMed ID: 11905820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traffic of proteins and peptides across membranes for immunosurveillance by CD8(+) T lymphocytes: a topological challenge.
    Johnstone C; Del Val M
    Traffic; 2007 Nov; 8(11):1486-94. PubMed ID: 17822406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative aspects of T cell activation--peptide generation and editing by MHC class I molecules.
    Stevanović S; Schild H
    Semin Immunol; 1999 Dec; 11(6):375-84. PubMed ID: 10625591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular organelles involved in antigen processing and the binding of peptides to class II MHC molecules.
    Harding CV
    Semin Immunol; 1995 Dec; 7(6):355-60. PubMed ID: 8775461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MHC class II-associated invariant chain: a molecule with multiple roles in MHC class II biosynthesis and antigen presentation to CD4+ T cells.
    Bertolino P; Rabourdin-Combe C
    Crit Rev Immunol; 1996; 16(4):359-79. PubMed ID: 8954255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
    Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
    J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between staphylococcal superantigens and MHC class II molecules.
    Labrecque N; Thibodeau J; Sékaly RP
    Semin Immunol; 1993 Feb; 5(1):23-32. PubMed ID: 8467091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells.
    Svensson M; Stockinger B; Wick MJ
    J Immunol; 1997 May; 158(9):4229-36. PubMed ID: 9126984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HLA system, antigen processing and presentation.
    Krensky AM
    Kidney Int Suppl; 1997 Mar; 58():S2-7. PubMed ID: 9067934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma.
    Frandji P; Oskéritzian C; Cacaraci F; Lapeyre J; Peronet R; David B; Guillet JG; Mécheri S
    J Immunol; 1993 Dec; 151(11):6318-28. PubMed ID: 8245470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principles of MHC class I-mediated antigen presentation and T cell selection.
    Ljunggren HG; Thorpe CJ
    Histol Histopathol; 1996 Jan; 11(1):267-74. PubMed ID: 8720469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.